Long-term outcomes in patients aged 70 years or less with intravenous glyburide from the phase II GAMES-RP study of large hemispheric infarction: an exploratory analysis.

BACKGROUND AND PURPOSE: We aimed to determine whether subjects aged ≤70 years who were treated with intravenous glyburide (RP-1127; BIIB093; glibenclamide) would have better long-term outcomes than those who received placebo. METHODS: Glyburide Advantage in Malignant Edema and Stroke-Remedy Pharmace...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stroke
Hlavní autoři: Sheth, Kevin N., Petersen, Nils H., Cheung, Ken, Elm, Jordan J., Hinson, Holly E., Molyneaux, Bradley J., Beslow, Lauren A., Sze, Gordon K., Simard, J. Marc, Kimberly, W. Taylor
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192530/
https://ncbi.nlm.nih.gov/pubmed/29789393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.020365
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky